NAFDAC's 5+5 Policy Drives Foreign Investment and Strengthens Local Pharmaceutical Production
The National Agency for Food and Drug Administration and Control (NAFDAC) has announced a significant increase in foreign investment within Nigeria's pharmaceutical sector, attributing this growth to the successful implementation of its 5+5 Policy. This strategic initiative, designed to promote local medicine production, was highlighted in a recent post on NAFDAC's official X account, underscoring the agency's efforts to enhance domestic manufacturing capabilities.
Policy Implementation and Impact
Introduced in 2018 under the leadership of Director-General Prof. Mojisola Adeyeye, the 5+5 Policy has encouraged numerous foreign companies to establish manufacturing facilities in Nigeria and form partnerships with indigenous firms. This move has not only boosted local production capacity but also significantly reduced the country's reliance on imported medicines, contributing to improved drug security and economic resilience.
Enhanced Investor Confidence
During a courtesy visit by the Indonesian Ambassador to Nigeria, Ambassador Bambang Suharto, in Abuja, Prof. Adeyeye emphasized that Nigeria's achievement of World Health Organization (WHO) Maturity Level 3, along with its 2025 recertification for regulating medicines and vaccines, has played a crucial role in bolstering investor confidence. She also pointed to NAFDAC's state-of-the-art Biologics and Vaccines Laboratory in Lagos as a key asset that strengthens the nation's regulatory and production frameworks, making Nigeria an attractive destination for pharmaceutical investments.
Commitment to Local Manufacturing
Prof. Adeyeye reaffirmed NAFDAC's dedication to supporting investors under the 5+5 policy, which operates as an import-to-local production strategy. This policy mandates that companies transition to domestic manufacturing within a specified timeframe, ensuring a steady shift towards self-sufficiency. She stressed that this approach is central to improving access to high-quality medicines, enhancing drug security, and driving sustainable economic growth across the country.
International Collaboration and Future Prospects
In response, Ambassador Suharto commended NAFDAC's leadership and expressed Indonesia's keen interest in deepening bilateral collaboration. He proposed a Memorandum of Understanding (MoU) to enhance trade relations, facilitate technical exchanges, and support capacity-building initiatives between the two nations. This potential partnership underscores the global recognition of Nigeria's growing pharmaceutical sector and the effectiveness of NAFDAC's policies in fostering international cooperation and investment.
